SecSonar.com

Dyadic International, Inc. (DYAI)

Dyadic International, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Dyadic International, Inc. (DYAI) is a Biotechnology company based in US with a market capitalization of $27.9M. Revenue declined 64.7% year-over-year and free cash flow was negative at -$5.7M. This page tracks DYAI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 6 employees · IPO Jan 16, 2008

Valuation

Valuation & price

$0.72 · as of May 17, 2026 · -44.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

22.62

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.22$0.95$0.68Jul 25Dec 25Jul 26Jul 7, 25$0.92Jul 9, 25$0.96Jul 11, 25$0.99Jul 15, 25$0.98Jul 17, 25$0.98Jul 21, 25$1.00Jul 23, 25$1.10Jul 25, 25$1.10Jul 29, 25$1.18Jul 31, 25$1.06Aug 4, 25$1.01Aug 6, 25$0.99Aug 11, 25$0.81Aug 13, 25$0.82Aug 15, 25$0.75Aug 19, 25$0.79Aug 21, 25$0.78Aug 25, 25$0.87Aug 27, 25$0.93Aug 29, 25$0.92Sep 3, 25$0.98Sep 5, 25$0.91Sep 9, 25$0.98Sep 11, 25$0.99Sep 16, 25$0.99Sep 18, 25$0.98Sep 22, 25$1.03Sep 24, 25$1.15Sep 26, 25$1.10Sep 30, 25$1.18Oct 2, 25$1.22Oct 6, 25$1.18Oct 8, 25$1.13Oct 10, 25$1.05Oct 14, 25$1.05Oct 16, 25$1.05Oct 21, 25$1.11Oct 23, 25$1.18Oct 27, 25$1.18Oct 29, 25$1.10Oct 31, 25$1.13Nov 4, 25$1.05Nov 6, 25$0.98Nov 10, 25$1.00Nov 12, 25$0.94Nov 14, 25$0.91Nov 18, 25$0.90Nov 20, 25$0.93Nov 25, 25$0.95Nov 28, 25$0.95Dec 2, 25$0.91Dec 4, 25$1.00Dec 8, 25$0.99Dec 10, 25$0.99Dec 12, 25$0.91Dec 16, 25$0.91Dec 18, 25$0.91Dec 22, 25$1.00Dec 24, 25$0.98Dec 29, 25$0.89Jan 2, 26$0.94Jan 6, 26$0.93Jan 8, 26$0.97Jan 12, 26$0.93Jan 14, 26$0.88Jan 16, 26$0.87Jan 21, 26$0.89Jan 23, 26$0.90Jan 27, 26$0.88Jan 29, 26$0.91Feb 2, 26$0.86Feb 4, 26$0.85Feb 9, 26$0.83Feb 11, 26$0.80Feb 13, 26$0.83Feb 18, 26$0.81Feb 20, 26$0.80Feb 24, 26$0.82Feb 26, 26$0.78Mar 2, 26$0.77Mar 4, 26$0.82Mar 6, 26$0.77Mar 10, 26$0.83Mar 12, 26$0.76Mar 17, 26$0.80Mar 19, 26$0.80Mar 23, 26$0.86Mar 25, 26$0.87Mar 27, 26$0.68Mar 31, 26$0.82Apr 2, 26$0.89Apr 7, 26$0.88Apr 9, 26$0.88Apr 13, 26$0.86Apr 15, 26$0.88Apr 17, 26$0.88Apr 22, 26$0.83Apr 24, 26$0.86Apr 28, 26$0.81Apr 30, 26$0.78May 4, 26$0.75May 6, 26$0.76May 8, 26$0.77May 12, 26$0.72May 14, 26$0.69May 18, 26$0.72May 20, 26$0.74May 22, 26$0.76May 28, 26$0.71Jun 1, 26$0.78Jun 3, 26$0.70Jun 5, 26$0.71Jun 9, 26$0.68Jun 11, 26$0.68Jun 15, 26$0.80Jun 17, 26$0.85Jun 22, 26$0.78Jun 24, 26$0.73Jun 26, 26$0.80Jul 2, 26$0.94
$0.6852-week range$1.30
Loading valuation history…

Fundamentals

Key fundamentals

$27.9M

Market cap

-64.7%

Revenue growth (YoY)

-88.3%

Gross margin

-$5.7M

Free cash flow (USD)

-$2.3M

Net debt

Net cash position

11.3%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$592.9KFY 2017$758.4KFY 2018$1.3MFY 2019$1.7MFY 2020$1.6MFY 2021$2.4MFY 2022$2.9MFY 2023$2.9MFY 2024$3.5MFY 2025$1.2M
$592.9K$1.2M

Free cash flow by year

2016 → 2025

FY 2016$-6.0MFY 2017$-2.6MFY 2018$-4.4MFY 2019$-5.8MFY 2020$-6.6MFY 2021$-11.3MFY 2022$-8.1MFY 2023$-6.7MFY 2024$-4.0MFY 2025$-5.7M
-$6M-$5.7M

Gross margin by year

2021 → 2025

FY 202119.1%FY 202227.5%FY 202331.8%FY 202465.8%FY 2025-88.3%
19.1%-88.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventDelisting NoticeJun 18, 2026Filing
  • 8-K eventPress Release IssuedJun 15, 2026Filing
  • 8-K eventCollaboration AnnouncementMay 28, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is Dyadic International, Inc.'s market cap?

Dyadic International, Inc. (DYAI) has a market capitalization of $27.9M.

What is DYAI's P/E ratio?

A meaningful P/E ratio is not available for DYAI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is DYAI's price-to-book (P/B) ratio?

DYAI trades at 22.62 times book value per share.

Are insiders buying DYAI stock?

SEC Form 4 filings show no open-market insider buys at Dyadic International, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

BRNS

Barinthus Biotherapeutics plc

$27.9M

IGC

IGC Pharma, Inc.

$28.7M

LSTA

Lisata Therapeutics, Inc.

$28.8M

ALLR

Allarity Therapeutics, Inc.

$26M

EVAX

Evaxion Biotech A/S

$25.8M

OTLK

Outlook Therapeutics, Inc.

$30M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.